TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/13/19 08:38 | 11/12/19 | CLSD | Clearside Biomedical, Inc. | GA | Health | Drug | Pharmaceutical Preparations | Deignan Charles A. | GA | O | CFO | P | 9 | 1.14 | 0 | 8 | 4 | 204 | D | ||||||||||||||
3/18/19 08:03 | 3/15/19 | CLSD | Clearside Biomedical, Inc. | GA | Health | Drug | Pharmaceutical Preparations | Deignan Charles A. | GA | O | CFO | P | 14 | 1.36 | 0 | 10 | 15 | 76 | D | ||||||||||||||
3/26/18 17:21 | 3/23/18 | CLSD | Clearside Biomedical, Inc. | GA | Health | Drug | Pharmaceutical Preparations | Deignan Charles A. | GA | O | CFO | P | 6 | 11.79 | 0 | 1 | 1 | 66 | D | ||||||||||||||
8/14/17 17:01 | 8/14/17 | CLSD | Clearside Biomedical, Inc. | GA | Health | Drug | Pharmaceutical Preparations | Deignan Charles A. | GA | O | CFO | P | 7 | 7.07 | 0 | 1 | 2 | 65 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |